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622a Wednesday, March 4, 2009force-frequency relation by X-ray diffraction (XRD) analysis at third-genera-
tion synchrotron facility. Methods: Seven isolated isovolumically contracting
rat hearts were paced at 120, 240, and 300bpm after complete heart block,
mounted so that the X-ray beam (15.0keV) passed the left ventricular (LV)
free wall, and perfused with Tyrode solution bubbled with 100% O2. LV vol-
ume were adjusted through water filled thin latex balloon inserted into LV cav-
ity so that end-diastolic LV pressure (LVP) was 0 mmHg. The amount of AMI
was evaluated by the minimum value of the intensity ratio of inner (1,0) and
outer (1,1) equatorial reflections (Imin) provided by anaysis of XRD. Between
three different HRs, we compared the amount of AMI and LVP. We also mea-
sured frequency-dependent changes in Ca2þ transient in sliced myocardial
preparations at 0.5, 1.0, and 2.0Hz. Results: In all hearts, we did not observe
incomplete relaxations. As increasing HR at 120, 240, and 300bpm, LVP sig-
nificantly decreased (66518, 51516, and 47518mmHg, respectively) and
Imin also significantly increased (0.9350.16, 1.2050.11, and 1.5650.18, re-
spectively), indicating a significant decrease of the amount of AMI. The dura-
tions of Ca2þ transient at 20% developed level at stimulating frequency of 0.5,
1.0, and 2.0Hz were significantly shortened (233525, 206534, and
171528ms, respectively). Conclusion: Increasing HR reduces the AMI. Ab-
sence of incomplete relaxations indicates intact intracellular Ca2þ handling.
These results may derive from shortening the period of Ca2þ-myofilament in-
teraction with increasing HR.
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The function of the heart is characterized by nonuniform wall motions working
coordinately to generate a smooth and effective pump action; however, the
functional importance of these heterogeneous motions are largely unknown.
To bridge the understanding of the basis for regional variations in contraction,
we have analyzed left ventricular free-wall motion using echocardiography and
sonomicrometry and quantified the expression of protein levels and post-trans-
lational modifications using gel electrophoresis. Porcine myocardium was used
for investigation and a stress test, i.e. dobutamine infusion, was performed to
amplify transmural contractile gradients during beta-adrenergic stimulation.
Here we report greater segmental shortening, strain and strain rate in the endo-
cardium compared to the epicardium in both the longitudinal and circumferen-
tial directions (p<0.05), but not in the radial dimension, at baseline and during
dobutamine infusion. The gradient of strain and shortening mirrors the expres-
sion of the myosin heavy chain isoforms, alpha- and beta-MyHC, across the
wall, i.e., there is more alpha-MyHC in the epicardium. We propose that differ-
ences in expression of specific protein isoforms in healthy, control myocardium
is directly related to the shorter period of stretch in the epicardium during the
heart cycle, or stretch activation, and that differences in myosin heavy chain
isoform content is a direct determinant of the strain differential. This work sup-
ported by NIH RO1-HL61635 (RLM) and T32-HL07936 (HSN).
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Hypertrophic (HCM), dilated (DCM) and restrictive (RCM) cardiomyopathies
are cardiac disorders often resulting from contractile protein mutations. They
are frequently dominantly inherited and are characterized by a high degree
of clinical heterogeneity proposed to result from modifying genetic factors.
For example, HCM patients with multiple causal mutations present a more se-
vere phenotype compared to single-mutation carriers. We employed high-speed
digital video imaging and novel motion detection software to characterize
in vivo cardiac structure and performance of homozygous Drosophila mutants,
quantitatively assessing cardiac diameters, contractile periodicities, fractional
shortening and rhythmicity parameters. Fly hearts expressing myosin with de-
pressed or enhanced biomechanical properties exhibited hallmarks of human
DCM or RCM respectively. To determine if the Drosophila cardiac phenotypes
exhibit dominant modes of inheritance we studied the effects of heterozygotic
expression of the myosin mutations. Interestingly, both mutations induced
dominant cardiac dilatory responses. This suggests the homozygotic RCM-
like phenotype is initiated by a unique cardiac remodeling pathway not acti-
vated in the presence of a wild-type myosin gene copy. We also used live-cell imaging and fluorescent microscopy to measure normalized cardiac tube
area, in order to investigate polygenic effects of specific sarcomeric mutations
on the severity of cardiac phenotypes in double heterozygotes. Combining a di-
lation-inducing troponin I mutation with the reduced function myosin mutation
resulted in a dilatory cardiac phenotype at advanced age, which was more se-
vere than that observed in single heterozygotes. However, combining the tropo-
nin mutation with the increased function myosin mutation appeared to prevent
the cardiac dilation characteristic of the single heterozygotes. This suggests
molecular combinations of certain mutations may have cardioprotective ef-
fects. Thus, Drosophila may serve as an effective in vivo tool for identifying
and studying genetic enhancers and suppressors of cardiac dysfunction.
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Background: In vertebrates, there are two kinds of myocardium, compacta and
spongiosa, which are associated with blood supply systems i.e. coronary and
sinusoidal circulation. To characterize the diastolic properties of these two
types of ventricles, we analyzed the ventricular end-diastolic pressure-volume
relationships (EDPVR) in rat and frog heart that include integrated expression
of chamber geometry and passive material properties of myocardial wall.
Methods: Pressure of rat left ventricule and frog ventricule was recorded to ob-
tain EDPVRs under isovolumic contractions with increases of ventricular vol-
ume to ~10 mmHg. The curvature changes of EDPVRs were described by non-
linear function. (EDP ¼ aEDV6 þ b).
Results: Ventricular volumes were normalized by ventricular weights. The vol-
umes from rat and frog ventricles that provided pressure of 10 mmHg were 0.6
and 2.5 mL/g respectively. EDPVRs from rat and frog showed common shape
(see Figure). The values of
a were 349 5 39 and
0.677 5 0.120 (n ¼ 3) in
rats and frogs respectively.
Discussion: Frog spongy
ventricles showed higher ex-
pandability than rat left ven-
tricles composed of compact
myocardium. Compact myo-
cardium with coronary cir-
culation might trade ventric-
ular expandability in return
for higher contractility.3209-Pos Board B256
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While the dynamic function of protein kinase D (PKD) has remained enig-
matic, recent work has shown that PKD phosphorylates the nuclear regulators
HDAC5/7 and CREB in the heart and has been implicated in the maintenance
of cellular dysfunction that develops in heart failure. Here we significantly ex-
tend our understanding of PKD signaling in heart by investigating the cytosolic
targeting of PKD in adult rat ventricular myocytes (ARVMs) using a molecular
genetic approach to drive adenovirus-dependent expression of wild type (wt),
constitutively active (ca) or dominant negative (dn) PKD in cultured ARVMs.
Confocal imaging reveals a significant distribution of PKD in a non-nuclear,
striated-reticular pattern in steady-state ARVMs with changes in PKD spatial
distribution as PKD activity changes. Consistent with an established role of
PKD in targeting cardiac troponin I, caPKD expression led to a marked de-
crease in contractile myofilament Ca2þ sensitivity. Steady-state Ca2þ transients
were markedly increased in dnPKD cells and are explained in part by a marked
increase in sarcoplasmic reticulum (SR) Ca2þ load. In addition, changes in the
cardiac Ca2þ current (ICa) and behavior of the phosphatase inhibitor calyculin
A (CalyA) support a role for PKD as a dynamic regulatory kinase of the L-type
Ca2þ channel (LTCC). Whole-cell voltage clamp studies illustrate a marked in-
crease in ICa throughout the entire voltage range in caPKD cells. Dynamic anal-
yses of ICa reveal that, unlike control cells, the Ca
2þ current in caPKD cells was
maximally activated and did not further increase after phosphatase inhibition,
while there was a loss of the CalyA stimulatory response in dnPKD cells. Taken
together with our new findings, work to date suggests a complex collection of
Wednesday, March 4, 2009 623afunctions carried out by PKD that can best be explained by a new model that
requires specific spatially-resolved subcellular targeting.
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Estrogen (E2) is a well-known cardioprotective steroid hormone. Although
heart has all the machinery to biosynthesize estrogen from testosterone by
cytochrome P450 aromatase, little is known about the role of local heart E2
concentration [E2] in cardioprotection. We hypothesized that high heart
[E2] in females could be one mechanism for the higher cardioprotection in
females. We optimized the radioimmunoassay technique to measure heart
[E2] in whole homogenate by diethyl ether extraction. Male mouse hearts
have significantly higher E2 levels (3553 pg/ml, n¼6) than plasma
(1250.9 pg/ml, n¼5). Heart [E2] in female mice at estrus and diestrus (dies-
trus 20.251.5 pg/ml n¼4; estrus 17.250.9 pg/ml, n¼4) were very similar to
plasma [E2]. Interestingly, in the proestrus stage, heart [E2] was extremely
high ~ 17054 pg/ml, almost 3 times higher than plasma [E2]. The final heart
[E2] will depend on the testosterone level as well as the efficiency of the ar-
omatase to convert testosterone to E2. As females have much lower levels of
testosterone (~40pg/ml at estrus and diestrus and ~240 pg/ml in proestrus)
compared to males (2 ng/ml), much higher heart [E2] in females at proestrus
compared to male lead us to hypothesize that the aromatase expression/activ-
ity is much higher in females than males. We performed real time PCR and
western blot analysis to quantify transcript and protein levels of aromatase
in male and in female mice at estrus stage, as this stage is under the control
of the preceding estrogen peak at proestrus. Aromatase transcript levels were
similar in males and females at estrus, but aromatase protein levels were two
fold higher in estrus compared to male. We speculate higher aromatase ex-
pression in females may underline its high estrogen content, thus resulting
in cardioprotection.
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Isoflavones such as genistein and daidzein prevented agonist-induced vascular
contraction in isolated rat aortic rings. Glyceollins are derived from the parent
isoflavone daidzein through a series of pterocarpan intermediates. We hypoth-
esized that glyceollin attenuates vascular contractions through inhibition of
RhoA/Rho kinase pathway. Rat aortic rings were denuded of endothelium,
mounted in organ baths and treated with either glyceollin (20 or 100 mM) or
vehicle (DMSO) for 60 min after submaximal contraction by NaF (8.0 mM).
The phosphorylation level of the myosin light chain (MLC20), myosin phospha-
tase target subunit 1 (MYPT1) and protein kinase C (PKC)-potentiated inhib-
itory protein for heterotrimeric myosin light chain phosphatase of 17-kDa
(CPI17) were determined by means of the Western blot. Glyceollin not only in-
hibited vascular contractions induced by NaF (8.0 mM), but also decreased the
activation of RhoA and subsequent phosphorylation of MYPT1Thr855 and
CPI17Thr38. These results indicate that glyceollin attenuates vascular contrac-
tion by inhibiting RhoA/Rho-kinase signaling.
3212-Pos Board B259
17b-Estradiol Attenuates Vascular Contraction Through Inhibition Of
RhoA/Rho Kinase Signaling Pathway
Enyue Yang1, Su Bun Jeon2, Inji Baek2, Min-Ji Song2, In Kyeom Kim2.
1Department of Pharmacology, Kyungpook National University School of
Medicine, Daegu, Republic of Korea, 2Kyungpook National University
School of Medicine, Daegu, Republic of Korea.
It is now well-known that 17b-estradiol has an endothelium-independent, non-
genomic vasorelaxant action. In the present study, we hypothesized that 17b-
estradiol attenuates vascular contraction by inhibiting RhoA/Rho kinase signal-
ing pathway in rat aorta. Rat aortic rings were denuded of endothelium,
mounted in organ baths, and contracted with 30 nM U46619 or 8.0 mM NaF
30 min after pretreatment with 17b-estradiol (30 and 100 mM) or vehicle.
We measured the amount of GTP RhoA and the level of phosphorylation of
the myosin light chain (MLC20), myosin phosphatase targeting subunit 1
(MYPT1) and PKC-potentiated inhibitory protein for heterotrimeric MLCP
of 17 kDa (CPI17). Pretreatment with 17b-estradiol not only inhibited
U46619- or NaF-induced vasocontractions and the phosphorylation ofMLC20 but also inhibited activation of RhoA. 17b-Estradiol also decreased
the level of phosphorylation of MYPT1Thr855 and CPI17Thr38, downstream ef-
fectors of Rho-kinase. In conclusion, 17b-estradiol attenuates vascular contrac-
tion, at least in part, through inhibition of RhoA/Rho kinase signaling pathway.
Key Words: 17b-estradiol, RhoA, Rho kinase, CPI-17, MYPT1, vasorelaxa-
tion
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Naþ-Hþ exchange (NHE) is the principal acid-extrusion mechanism in cardiac
myocytes. Its activity has been linked to myocardial ischaemia-reperfusion in-
jury, arrhythmia and the development of cardiac hypertrophy. NHE is modu-
lated acutely by intracellular pH (pHi), as well as through phosphorylation
by kinases. Nitric oxide (NO) is an important regulator of cardiac function. It
is synthesised by NO synthases (NOS), which are activated by muscarinic
(M2) receptors. NO targets proteins, partly via protein kinase G, which is acti-
vated by cyclic GMP (cGMP). We studied the effect of this regulatory pathway
on NHE activity in rat ventricular myocytes. Myocytes were loaded with the
acetoxymethyl-ester of carboxy-SNARF-1 (a pH-reporter dye) and superfused
with Hepes-buffer at 37C. Applying a 4min, 20mM NH4Cl prepulse deposits
an intracellular acid-load that stimulates NHE. The membrane-permeant cGMP
analog 8Br-cGMP (20mM), the NO donor sodium nitroprusside (1mM) and the
M2 agonist carbachol (100mM) reduced NHE activity (vs paired controls). At
a common pHi of 6.6, NHE inhibition was 26%, 29% and 18%, respectively
(P>0.05). We also transfected adult myocytes with the nNOS gene using an ad-
enoviral system (51010 viral particles, incubated overnight) to increase NO
production capacity. To confirm successful gene-transfer, eGFP was trans-
fected in separate experiments and fluorescence was detected in>90% of cells.
NHE activity at pHi¼6.6 was not significantly different in nNOS-transfected
cells (vs sham-transfected cells). However, on addition of carbachol
(100mM), NHE activity was reduced by 50%. These findings illustrate an im-
portant role for the NO/cGMP pathway in modulating pHi homeostasis.
Work supported by the British Heart Foundation and Wellcome Trust.
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We have investigated the effect of cell orientation on the observed colocaliza-
tion of the ryanodine receptor (RyR) with the L-type calcium channel (Cav1.2)
in adult rat ventricular myocytes. Cells were embedded in 2% agarose1 and vi-
sualised with a 60X 1.2 NA water immersion objective on an Olympus FV1000
confocal microscope; all images were deconvolved before analysis. We imaged
cells oriented both parallel and perpendicular to the coverslip. We found that
colocalization between RyR and Cav1.2 in the two orientations was not signif-
icantly different from each other, and similar to values previously reported2.
Cells oriented perpendicular to the coverslip provided additional details of
the colocalization: The colocalized region between RyR and Cav1.2 was often
surrounded by an area of RyR fluorescence, implying that the calcium channels
within a dyad cover a smaller area than do the RyR. RyR that had no corre-
sponding Cav1.2, and are presumed to be extra-dyadic, were distributed in
the Z disk with no discernable pattern.
1. Chen-Izu, Y, et al. (2006) Biophys. J 91: 1-13.
2. Scriven, DR, et al. (2000) Biophys. J. 79: 2682-2691.
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mulation During Sodium Pump Inhibition
Kirsten Hoyer1, James Balschi2, John Shryock1, Luiz Belardinelli1, Joanne
S. Ingwall2.
1CV Therapeutics, Inc., Palo Alto, CA, USA, 2Brigham and Women’s
Hospital, Harvard Med School, Boston, MA, USA.
Impairment of Naþ/Kþ-ATPase activity reduces sodium efflux and leads to an
increase in intracellular Naþ (Naþi). We tested the hypothesis that Na
þ accu-
mulation caused by ouabain, a Naþ/Kþ-ATPase inhibitor, would be reduced
by concurrent inhibition of the late sodium current (INaL). We measured
Naþi, high energy phosphates, and chemical driving force (DG~ATP) in isolated
guinea pig hearts in real time with 23Na- and 31P- NMR. Hearts were pre-
